Author: Wang DanHong
KariStef Nsson is conceiving a new genome company. (The picture is offered: <
According to Science published newly, a lot of observers think this dreary reality show, what a difficult thing is one it to obtain profits from human genome research. However, this company and its famous president KariStef Nsson will not go with the wind, the company will depend on the loan that the potential buyer offers continues running. Stef Nsson shows that hopes to continue keeping in the company, takes the post as the person in charge of research department who pursues the disease gene.
1996, Stef in a scene of dispute sound Nsson has established the gene and decoded the company, aims at collecting Icelandic residents' genome data, carry on comprehensive comparative analysis of they, medical science and family's data, look for the genetic sign of disease through excavating these biological data banks. However, though the gene decoded the research of the company obtained thunderous applause, having produced the thesis of a lot of high influence, but the company hoped to obtain efforts of the profit while testing from new medicine development and gene failed. In the past several years, company sell his assets so that self-insurance straight.
In summer of 2008, this company once linked the trust of health to discuss with the biomedical charity organization of Britain that accepted and supported the biological bank matters, but both sides have not reached any agreement. Stef Statement that relevant companies limit the data on this incident and share that nsson has denied, he says, the basic reason not reaching an agreement is to link the trust of health and hope to operate the gene to decode in the form of non-commercial research institution, but this is impossible, because the company has legal liability that pays the profit for investors. However, he is " still exposed to our way to move in order to link the health company " .
Replaced, the company has been chosen another life style. At the beginning of November, the gene decodes the application for bankrupt protection that the parent company in U.S.A. puts forward chapter 11 of U.S.A.'s federal bankruptcy law to Delaware State, mean the company will recombinate debts and make it not in debt any more. Nowadays, one of Iceland call Company that legend invest, already provide funds of 140 million dollars, the medicine development item of purchasing the gene and decoding the company and a branch company in Iceland, this company manages its biological bank and hereditary test service. However, the parent company of this company hopes through the certain debt and discharges and solves the dispute, and the holder of share does not hope to bring back their money either.
This trade needs to get the approval of the court at first, other bidders will join in too. Stef Nsson say, if the bid that the legend invest succeeds, then he hopes to take the post as the executive chairmans and research department presidents of the new company, in addition engage the CEO that rookies took the post as the company, is responsible for commerce's running.
Stef The project of nsson has already moved towards the next stage, namely look for the rare pathogenic variation gene. According to deduce, compared with pathogenic gene already found, gene these should have high pathogenic risk, and can offer the new clue for studying in physiology of disease. Stef Nsson says, by the middle period of 2011, he plans to measure more than 2500 people's intact genome array, and combine these data and family's data, look for, go out of Iceland incidence 0.1% genetic mutation only in the 320,000 total population enough in this way.
Researchers think, because the country such as Iceland looks for the rare variation in a family is a relatively easy thing, so, the gene decodes the company as establishing one through chance to make great efforts to succeed by oneself. The geneticist StephenChanock of research institute of U.S.A.'s cancer says, looks for the disease gene to need to date back to the place where they begin.
The famous biological drugmaker of Iceland applies to protect bankrupt
No comments:
Post a Comment